1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Perinatal thymic-derived CD8αβ-expressing γδ T cells are innate IFN-γ producers that expand in IL-7R–STAT5B-driven neoplasms

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The contribution of γδ T cells to immune responses is associated with rapid secretion of interferon-γ (IFN-γ). Here, we show a perinatal thymic wave of innate IFN-γ-producing γδ T cells that express CD8αβ heterodimers and expand in preclinical models of infection and cancer. Optimal CD8αβ + γδ T cell development is directed by low T cell receptor signaling and through provision of interleukin (IL)-4 and IL-7. This population is pathologically relevant as overactive, or constitutive, IL-7R–STAT5B signaling promotes a supraphysiological accumulation of CD8αβ + γδ T cells in the thymus and peripheral lymphoid organs in two mouse models of T cell neoplasia. Likewise, CD8αβ + γδ T cells define a distinct subset of human T cell acute lymphoblastic leukemia pediatric patients. This work characterizes the normal and malignant development of CD8αβ + γδ T cells that are enriched in early life and contribute to innate IFN-γ responses to infection and cancer.

          Abstract

          Here the authors identify and characterize the development and function of an IFN-γ-producing CD8αβ + subset of γδ T cells that contributes to malignancy.

          Related collections

          Most cited references57

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Metascape provides a biologist-oriented resource for the analysis of systems-level datasets

          A critical component in the interpretation of systems-level studies is the inference of enriched biological pathways and protein complexes contained within OMICs datasets. Successful analysis requires the integration of a broad set of current biological databases and the application of a robust analytical pipeline to produce readily interpretable results. Metascape is a web-based portal designed to provide a comprehensive gene list annotation and analysis resource for experimental biologists. In terms of design features, Metascape combines functional enrichment, interactome analysis, gene annotation, and membership search to leverage over 40 independent knowledgebases within one integrated portal. Additionally, it facilitates comparative analyses of datasets across multiple independent and orthogonal experiments. Metascape provides a significantly simplified user experience through a one-click Express Analysis interface to generate interpretable outputs. Taken together, Metascape is an effective and efficient tool for experimental biologists to comprehensively analyze and interpret OMICs-based studies in the big data era.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Treating childhood acute lymphoblastic leukemia without cranial irradiation.

            Prophylactic cranial irradiation has been a standard treatment in children with acute lymphoblastic leukemia (ALL) who are at high risk for central nervous system (CNS) relapse. We conducted a clinical trial to test whether prophylactic cranial irradiation could be omitted from treatment in all children with newly diagnosed ALL. A total of 498 patients who could be evaluated were enrolled. Treatment intensity was based on presenting features and the level of minimal residual disease after remission-induction treatment. The duration of continuous complete remission in the 71 patients who previously would have received prophylactic cranial irradiation was compared with that of 56 historical controls who received it. The 5-year event-free and overall survival probabilities for all 498 patients were 85.6% (95% confidence interval [CI], 79.9 to 91.3) and 93.5% (95% CI, 89.8 to 97.2), respectively. The 5-year cumulative risk of isolated CNS relapse was 2.7% (95% CI, 1.1 to 4.3), and that of any CNS relapse (including isolated relapse and combined relapse) was 3.9% (95% CI, 1.9 to 5.9). The 71 patients had significantly longer continuous complete remission than the 56 historical controls (P=0.04). All 11 patients with isolated CNS relapse remained in second remission for 0.4 to 5.5 years. CNS leukemia (CNS-3 status) or a traumatic lumbar puncture with blast cells at diagnosis and a high level of minimal residual disease (> or = 1%) after 6 weeks of remission induction were significantly associated with poorer event-free survival. Risk factors for CNS relapse included the genetic abnormality t(1;19)(TCF3-PBX1), any CNS involvement at diagnosis, and T-cell immunophenotype. Common adverse effects included allergic reactions to asparaginase, osteonecrosis, thrombosis, and disseminated fungal infection. With effective risk-adjusted chemotherapy, prophylactic cranial irradiation can be safely omitted from the treatment of childhood ALL. (ClinicalTrials.gov number, NCT00137111.) 2009 Massachusetts Medical Society
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              CD27 is a thymic determinant of the balance between interferon-gamma- and interleukin 17-producing gammadelta T cell subsets.

              The production of cytokines such as interferon-gamma and interleukin 17 by alphabeta and gammadelta T cells influences the outcome of immune responses. Here we show that most gammadelta T lymphocytes expressed the tumor necrosis factor receptor family member CD27 and secreted interferon-gamma, whereas interleukin 17 production was restricted to CD27(-) gammadelta T cells. In contrast to the apparent plasticity of alphabeta T cells, the cytokine profiles of these distinct gammadelta T cell subsets were essentially stable, even during infection. These phenotypes were established during thymic development, when CD27 functions as a regulator of the differentiation of gammadelta T cells at least in part by inducing expression of the lymphotoxin-beta receptor and genes associated with trans-conditioning and interferon-gamma production. Thus, the cytokine profiles of peripheral gammadelta T cells are predetermined mainly by a mechanism involving CD27.
                Bookmark

                Author and article information

                Contributors
                gina.fiala@biologie.uni-freiburg.de
                d.pennington@qmul.ac.uk
                Journal
                Nat Immunol
                Nat Immunol
                Nature Immunology
                Nature Publishing Group US (New York )
                1529-2908
                1529-2916
                27 May 2024
                27 May 2024
                2024
                : 25
                : 7
                : 1207-1217
                Affiliations
                [1 ]Blizard Institute, Barts and The London School of Medicine, Queen Mary University of London, ( https://ror.org/026zzn846) London, UK
                [2 ]GRID grid.9983.b, ISNI 0000 0001 2181 4263, Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, , Universidade de Lisboa, ; Lisboa, Portugal
                [3 ]Faculty of Biology, University of Freiburg, ( https://ror.org/0245cg223) Freiburg, Germany
                [4 ]Signalling Research Centres BIOSS and CIBSS, University of Freiburg, ( https://ror.org/0245cg223) Freiburg, Germany
                [5 ]Cancer Research UK Scotland Institute, Glasgow, UK
                [6 ]School of Cancer Sciences, University of Glasgow, ( https://ror.org/00vtgdb53) Glasgow, UK
                [7 ]St. Jude’s Children’s Research Hospital, ( https://ror.org/02r3e0967) Memphis, TN USA
                [8 ]GRID grid.508487.6, ISNI 0000 0004 7885 7602, Hôpital Necker Enfants-Malades, , Université de Paris, ; Paris, France
                [9 ]Department of Biosciences and Medical Biology, Paris Lodron University of Salzburg, ( https://ror.org/05gs8cd61) Salzburg, Austria
                [10 ]GRID grid.7708.8, ISNI 0000 0000 9428 7911, Center of Chronic Immunodeficiency CCI, , University Clinics and Medical Faculty, ; Freiburg, Germany
                Author information
                http://orcid.org/0000-0002-8226-5584
                http://orcid.org/0000-0002-2079-4413
                http://orcid.org/0000-0002-2158-467X
                http://orcid.org/0000-0001-8211-5538
                http://orcid.org/0000-0002-6255-5314
                http://orcid.org/0000-0002-1871-1850
                http://orcid.org/0000-0003-2257-2862
                http://orcid.org/0000-0003-0918-9463
                http://orcid.org/0000-0001-7889-9923
                Article
                1855
                10.1038/s41590-024-01855-4
                11224017
                38802512
                3b12d010-e831-4904-b4cd-b433ec92e119
                © The Author(s) 2024

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 13 March 2023
                : 25 April 2024
                Funding
                Funded by: FundRef https://doi.org/10.13039/501100000268, RCUK | Biotechnology and Biological Sciences Research Council (BBSRC);
                Award ID: BB/R017808/1
                Award ID: BB/R017808/1
                Award Recipient :
                Funded by: Neue Universitätsstiftung Freiburg “Come and STAY!”
                Funded by: Fundação para a Ciência e Tecnologia SFRH/BD/145352/2019
                Funded by: Fundação para a Ciência e Tecnologia PTDC/MED-ONC/6829/2020
                Funded by: Fundação para a Ciência e Tecnologia SFRH/BD/147411/2019
                Funded by: FundRef https://doi.org/10.13039/100010434, "la Caixa" Foundation (Caixa Foundation);
                Award ID: HR21-00761
                Award Recipient :
                Funded by: FundRef https://doi.org/10.13039/100011199, EC | EC Seventh Framework Programm | FP7 Ideas: European Research Council (FP7-IDEAS-ERC - Specific Programme: "Ideas" Implementing the Seventh Framework Programme of the European Community for Research, Technological Development and Demonstration Activities (2007 to 2013));
                Award ID: ERC-PoC-101069429
                Award Recipient :
                Categories
                Article
                Custom metadata
                © Springer Nature America, Inc. 2024

                Immunology
                lymphopoiesis,gammadelta t cells,leukaemia
                Immunology
                lymphopoiesis, gammadelta t cells, leukaemia

                Comments

                Comment on this article